1-methoxy-3-(m-tolyloxy)benzene | 189149-64-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-methoxy-3-(m-tolyloxy)benzene
• 英文别名: 1-Methoxy-3-m-tolyloxy-benzol；1-Methoxy-3-(3-methylphenoxy)benzene
• CAS: 189149-64-2
• 化学式: C₁₄H₁₄O₂
• 分子量: 214.264
• InChiKey: HEOOVQLYJBSKFJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-methoxy-3-(m-tolyloxy)benzene 在 potassium permanganate 作用下， 生成 3-(3-methoxyphenoxy)benzoic acid
  参考文献：
  名称：

  Methoxy (and Hydroxy) Phenoxybenzoic Acids

  摘要：

  DOI：

  10.1021/jo50002a021
• 作为产物：
  描述：

  3-碘苯甲醚 、 间甲酚 在 copper(II) bis(trifluoromethanesulfonate) 、 caesium carbonate 作用下， 以 1,4-二氧六环 为溶剂， 反应 22.0h， 以72%的产率得到1-methoxy-3-(m-tolyloxy)benzene
  参考文献：
  名称：

  高效的BINAM–铜（II）催化二芳基醚的Ullmann型合成

  摘要：

  在温和的反应条件下，在催化量的易得的BINAM-Cu（OTf）2络合物存在下，通过Ullmann型偶联反应，由相应的芳基碘化物和苯酚合成了大量的二芳基醚。还显示出反应性较低的芳基溴化物在相同的反应条件下可与酚反应，从而在不增加反应温度和时间的情况下获得良好的二芳基醚收率。

  DOI：

  10.1016/j.tetlet.2007.11.203

文献信息

• Low Catalyst Loadings for Copper-Catalyzed O-Arylation of Phenols with Aryl and Heteroaryl Halides under Mild Conditions
  作者：Yong-Chua Teo、Fui-Fong Yong、Yaw-Kai Yan、Guan-Leong Chua

  DOI：10.1055/s-0031-1290110

  日期：2012.1

  A practical and mild strategy has been developed for the cross-coupling of O-arylation of phenol with differently substituted aryl halides and heteroaryl iodides using low catalyst loading of copper iodide under low operating temperature in DMF with TMHD as the ligand and Cs2CO3 as the base. This method tolerates a variety of functional groups including sterically hindered phenols and heteroaryl iodides

  已经开发了一种实用且温和的策略，用于在 DMF 中以 TMHD 为配体和 Cs2CO3 为碱，在低操作温度下，使用低催化剂负载量的碘化铜将苯酚与不同取代的芳基卤化物和杂芳基碘化物的 O-芳基化交叉偶联. 该方法可耐受各种官能团，包括空间位阻酚和杂芳基碘化物，以提供良好至极好的产率（高达 95%）的产品。
• 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER
  申请人：Centre National de la Recherche Scientifique

  公开号：EP3915990A1

  公开（公告）日：2021-12-01

  The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases inhibitors. The present invention also concerns these new inhibitors for use for the treatment of a condition selected in the group consisting of: cancers, virion infections, ocular hypertension and glaucoma formation, Neurofibromatosis type 1 and 2, psoriatic lesions, inflammatory diseases and hyperalgesia, central sensitization and chronic pain, reproduction erectile dysfunction, and neuronal diseases. The present description discloses the syntheses and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 32 to 127; examples 1 to 96; families 1 to 8; compounds; biological studies; tables). An exemplary compound is e.g. 4-(5-m ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N-phenyl-3,6-dihydropyridine-1-(2H)-carboxamide (example 1; compound 5).

  本发明涉及一种化合物，特别是作为LIMK和/或ROCK激酶抑制剂的化合物（I）的公式。本发明还涉及这些新抑制剂的用途，用于治疗所选组中的疾病，包括：癌症、病毒感染、眼压增高和青光眼形成、神经纤维瘤病1和2型、银屑病损、炎症性疾病和过敏症、中枢敏化和慢性疼痛、生殖勃起功能障碍和神经疾病。本说明披露了示例化合物的合成和表征，以及其药理学数据（例如第32至127页；示例1至96；家族1至8；化合物；生物学研究；表格）。一个示例化合物是4-(5-甲基-7H-吡咯并[2,3-d]嘧啶-4-基)-N-苯基-3,6-二氢吡啶-1-(2H)-甲酰胺（示例1；化合物5）。
• OLIGO- AND POLYIMIDES
  申请人：Rome Daniel

  公开号：US20140135448A1

  公开（公告）日：2014-05-15

  An oligo- or polyimide comprising one or two residue(s) of an anhydride based acetylenic end-capper, at least one EBPA residue, at least one residue of anaromatic di-amine, and optionally at least one residue of an aromatic non-acetylenic di-anhydride is disclosed. A method for obtaining such an oligo- or polyimide is also disclosed.
• [EN] 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE DERIVATIVES AS LIMK AND/OR ROCK KINASES INHIBITORS FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3,6-DIHYDROPYRIDINE-1-(2H)-CARBOXAMIDE SERVANT D'INHIBITEURS DE KINASES LIMK ET/OU ROCK DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2021239727A1

  公开（公告）日：2021-12-02

  The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases inhibitors. The present invention also concerns these new inhibitors for use for the treatment of a condition selected in the group consisting of: cancers, virion infections, ocular hypertension and glaucoma formation, Neurofibromatosis type 1 and 2, psoriatic lesions, inflammatory diseases and hyperalgesia, central sensitization and chronic pain, reproduction erectile dysfunction, and neuronal diseases. The present description discloses the syntheses and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 37 to 163; examples 1 to 169; compounds; biological studies; tables; figure pages 1/6 to 6/6). An exemplary compound is e.g. 4-(5-methyl-7H-pyrrolo[2,3- d]pyrimidin-4-yl)-N-phenyl-3,6-dihydropyridine-1-(2H)-carboxamide (example 1; compound 5).
• Methoxy (and Hydroxy) Phenoxybenzoic Acids
  作者：Herbert E. Ungnade、Louis Rubin

  DOI：10.1021/jo50002a021

  日期：1951.8